Pharmaspectra enters partnership with IBM Watson Health

Pharmaspectra announces partnership with IBM Watson Health

Pharmaspectra, the world’s largest collection of medical science, today announced it has entered into a partnership with IBM Watson Health.

Through the partnership agreement, IBM Watson Health is withdrawing IBM Stakeholder Manager® from its portfolio and offering a transition path for its clients to Pharmaspectra’s product, LINK, the global leader in key opinion leader (KOL) management solutions.

Pharmaspectra is the leading provider of scientific data to the pharmaceutical industry, helping clients drive more effective interactions with healthcare professionals, optimise their product launches and strategic planning, and achieve scientific leadership. Pharmaspectra’s LINK solution combines the world’s leading scientific database, with superior analytics, connecting clients with the right scientific experts.

IBM Watson Health is committed to working closely with clients during this transition to provide a smooth introduction to Pharmaspectra’s LINK solution. IBM Watson Health is making these changes to streamline its portfolio to focus on new strategies and innovations to help support Life Sciences clients through the next stages of digital transformation.

Pharmaspectra Group Limited CEO, Jez Moulding stated, “I am delighted to enter this partnership with IBM as it enables us to further grow and develop our LINK KOL management solution. We look forward to the opportunity to work with IBM’s current clients and to continuing to deliver superior, actionable data and insights to all our partners.”